비용-편익분석을 활용한 연속혈당측정기 도입의 질병부담 경감 효과 평가
Evaluation of the Effects on Disease Burden Relief from Adopting Continuous Blood Glucose Monitoring System Utilizing Cost-benefit Analysis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The latest medical devices, applying advanced technologies, are aiding in the prevention and alleviation of suffering from specific diseases in daily life. Continuous glucose monitoring system (CGM), one of these devices, has helped type 1 diabetes patients alleviate the burden of disease since 2016. To explain the impact of CGM, this study aims at evaluating the economic validity and effectiveness of them by utilizing a cost-benefit analysis. This research presented net social benefit (NSB) and benefit-cost ratio (BCR) as result indicators from 2019 to 2022, compared to 2015. The result demonstrated the effectiveness of CGM in terms of both economic viability and disease management, as NSB and BCR had recorded effective value. However, both indicators have a decreasing trend each year due to the significant increase in cost associated with medical devices. It points out the following implications. First, a measure to reduce the cost of the medical device is necessary in order to keep the values of NSB and BCR within a valid range. It implies deregulation of medical device manufacturing is required, in that the domestic products are relatively inexpensive. Second, given that the prevalence rate of type 2 diabetes is high in an aging society, it is necessary to expand the coverage of insurance benefits for CGM, as a broader reduction in the burden of disease is expected.
Abstract
The latest medical devices, applying advanced technologies, are aiding in the prevention and alleviation of suffering from specific diseases in daily life. Continuous glucose monitoring system (CGM), one of these devices, has helped type 1 diabetes patients alleviate the burden of disease since 2016. To explain the impact of CGM, this study aims at evaluating the economic validity and effectiveness of them by utilizing a cost-benefit analysis. This research presented net social benefit (NSB) and benefit-cost ratio (BCR) as result indicators from 2019 to 2022, compared to 2015. The result demonstrated the effectiveness of CGM in terms of both economic viability and disease management, as NSB and BCR had recorded effective value. However, both indicators have a decreasing trend each year due to the significant increase in cost associated with medical devices. It points out the following implications. First, a measure to reduce the cost of the medical device is necessary in order to keep the values of NSB and BCR within a valid range. It implies deregulation of medical device manufacturing is required, in that the domestic products are relatively inexpensive. Second, given that the prevalence rate of type 2 diabetes is high in an aging society, it is necessary to expand the coverage of insurance benefits for CGM, as a broader reduction in the burden of disease is expected.
참고문헌 (16)
- "아이센스: 진행되는 투자와연속혈당측정 시장 진입 기대" (2022), 기업리서치센터[URL]
- 김병호, "권역심뇌혈관질환센터 사업의 비용-편익 분석", 보건정보통계학회지, 42(1), pp.16~26 (2017)
- 김원준, "연속혈당측정의 활용과 국내 지원현황에 대한입장 성명서", J Korean Diabetes, 22(4), pp.225~237 (2021)
- 김진현, "국민건강보험공단 진료비 자료를 활용한 65세 이상 방문건강관리사업 대상자의 비용-편익분석", 근관절건강학회지, 27(3), pp.238~246 (2020)
- "국민관심질병통계 입원외래별현황" (2023)[URL]
- "질병 세분류 4단 상병 통계 입원 외래별 현황(2013-2022)" (2023)[URL]
- "국민건강보험공단_현금급여비(당뇨병환자소모성재료) 지급현황_20221231" (2023)[URL]
- 신인숙, "국가수두예방접종사업의 비용-편익분석", 박사, pp.2020
- 임은실, "맞춤형 방문건강관리사업에서 노인을 대상으로 한 고혈압 사례관리 비용-편익 분석", 박사, 간호학, pp.2009
- 임지영, "비용편익분석을 이용한 일 재가노인간호센터의 고혈압및 당뇨관리 효과평가", 간호행정학회지, 16(3), pp.295~305 (2010)
- Drummond, M. F., "Methods for the Economic Evaluation of Health Care Programmes" (1997), Oxford Medical Publications
- Drummond, M. F., "Methods for the Economic Evaluation of Health Care Programmes" (2005), Oxford Medical Publications
- Floyd B, "Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus", Journal of Diabetes. Science&Technology, 6(5), pp.1094~1102 (2012)
- Kim, D. K., "Cost-benefit analysis" (1997), Parkyoungsa
- Poolsup N, "Systematic Review and Meta-analysis of the Effectiveness of Continuous Glucose Monitoring(CGM)on Glucose Control in Diabetes", Diabetology and Metabolic Syndrome, 5(39), pp.1~14 (2013)
- Willian H, Polinsky, "The Impact of Continuous Glucose Monitoring on the DIAMOND Randomized Clinical Trial", Diabetes Care, 40, pp.736~741 (2017)